Abstract
Current Drug Targets - Cardiovascular & Hematological Disorders
Title: Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression
Volume: 5 Issue: 6
Author(s): Paul Schoenhagen and Steven E. Nissen
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Schoenhagen Paul and Nissen E. Steven, Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression, Current Drug Targets - Cardiovascular & Hematological Disorders 2005; 5 (6) . https://dx.doi.org/10.2174/156800605774962013
DOI https://dx.doi.org/10.2174/156800605774962013 |
Print ISSN 1568-0061 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0061 |
Related Articles
-
The Pathophysiology of Uric Acid in Relation to Cardiovascular Disease
Current Cardiology Reviews The Endothelial-Mesenchymal Transition (EndMT) and Tissue Regeneration
Current Stem Cell Research & Therapy Fetzima (levomilnacipran), a Drug for Major Depressive Disorder as a Dual Inhibitor for Human Serotonin Transporters and Beta-Site Amyloid Precursor Protein Cleaving Enzyme-1
CNS & Neurological Disorders - Drug Targets Review of Vital Signs Monitoring Systems – Patient’s Acceptability, Issues and Challenges
Neuroscience and Biomedical Engineering (Discontinued) Aliphatic and Aromatic Oxidations, Epoxidation and S-Oxidation of Prodrugs that Yield Active Drug Metabolites
Current Medicinal Chemistry Transdermal Delivery of Captopril and Metoprolol Tartrate with Microneedles
Drug Delivery Letters Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations
Current Pharmaceutical Design Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response
Recent Patents on Inflammation & Allergy Drug Discovery Cellular and Molecular Regulation of Inflammatory Pain, Nociception and Hyperalgesia - The Role of the Transcription Factor NF-κB as the Lynchpin Nocisensor: Hyperalgesic or Analgesic Effect?
Current Immunology Reviews (Discontinued) Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Treating Arterial Stiffness in Young and Elderly Patients with the Metabolic Syndrome
Current Pharmaceutical Design New Generation Calcium Channel Blockers in Hypertensive Treatment
Current Hypertension Reviews Potential of Resveratrol in Preventing the Development of Heart Failure
Current Chemical Biology The MAPK / JNK Signalling Pathway Offers Potential Therapeutic Targets for the Prevention of Acquired Deafness
Current Drug Targets - CNS & Neurological Disorders Meet Our Section Editor
Current Vascular Pharmacology Isotyping the Human TOMM40 Variable-Length Polymorphism by Gene Amplification and Restriction Digest
Current Alzheimer Research Molecular Players at the Intersection of Obesity and Osteoarthritis
Current Drug Targets Identifying Risk Factors for Clinically Significant Diabetic Macula Edema in Patients with Type 2 Diabetes Mellitus
Current Diabetes Reviews Early Growth Response-1 (EGR-1) – A Key player in Myocardial Cell Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Mediterranean Diet and Longevity
Current Nutrition & Food Science